In a research report published Tuesday, Cowen analyst Ritu Baral reiterated an Outperform rating on shares of Sarepta Therapeutics Inc (NASDAQ:SRPT), with a …
After Incyte Corporation (NASDAQ:INCY) announced positive clinical pipeline updates that had investors celebrating and shares soaring 9%, top analyst Eric Schmidt at Cowen …
In a research report released today, Cowen analyst Eric Schmidt reiterated a Market Perform rating on shares of Merrimack Pharmaceuticals Inc (NASDAQ:MACK), after …
Ionis Pharmaceuticals Inc (NASDAQ:IONS) shares were initially up 6% this morning after the biotech firm and its wholly-owned subsidiary Akcea Therapeutics signed an …
Cempra Inc (NASDAQ:CEMP) shares collapsed 57% yesterday after the firm received a Complete Response Letter (CRL) from the FDA for its pipeline drug …
Cowen analyst Chris Shibutani remains sidelined, but optimistic on Lexicon Pharmaceuticals (NASDAQ:LXRX) after the firm released a positive top-line readout from InTandem2, the second of its three pivotal Phase III trials …
Biogen Inc (NASDAQ:BIIB) has decided to promote from within, opting to transition Chief Commercial Officer Michel Vounatsos into the role of CEO, a …
Loxo Oncology Inc (NASDAQ:LOXO) gave investors cause to celebrate today, to the tune of shares rocketing 26%, after providing an encouraging regulatory update …
Cowen analyst Ritu Baral is chiming in with her two cents on Sarepta Therapeutics Inc (NASDAQ:SRPT) as to what the early days of …
Cowen analyst John Blackledge is all the more bullish on Netflix, Inc. (NASDAQ:NFLX) following CEO of Charter Tom Rutledge’s recent comments at an …
